Presentation is loading. Please wait.

Presentation is loading. Please wait.

Efficacy and safety of dupilumab for the treatment of adult atopic dermatitis: A meta- analysis of randomized clinical trials  Yue Han, MD, Yuxin Chen,

Published byῬέα Λύκος Modified over 5 years ago

Similar presentations

Presentation on theme: "Efficacy and safety of dupilumab for the treatment of adult atopic dermatitis: A meta- analysis of randomized clinical trials  Yue Han, MD, Yuxin Chen,"— Presentation transcript:

1 Efficacy and safety of dupilumab for the treatment of adult atopic dermatitis: A meta- analysis of randomized clinical trials  Yue Han, MD, Yuxin Chen, PhD, Xiaochun Liu, MD, Jingxi Zhang, MD, Huichun Su, MD, He Wen, MD, Wei Li, MD, PhD, Xu Yao, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 140, Issue 3, Pages e6 (September 2017) DOI: /j.jaci Copyright © Terms and Conditions

2 Fig 1 Meta-analysis of efficacy outcomes of 7 RCTs with dupilumab- and placebo-treated patients with AD. A, The EASI score. B, The IGA score. C, Pruritus numerical-rating scale (NRS) score. D, Body surface area (BSA) score. Horizontal lines stand for 95% Cls of the RR estimates. Green dots represent the SMD. Blue dots represent the RR, and diamonds represent the meta-analysis summary effect estimate. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © Terms and Conditions

3 Fig E1 Study selection process. We collected 167 potentially relevant studies, of which 7 were included in the meta-analysis. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © Terms and Conditions

4 Fig E2 A, Risk of bias summary for each included study. B, Begg funnel plot. Studies with larger scale have been spread around the average, and publications with smaller scale were plodded evenly on each side of the average. Deviation from such funnel-like distribution is able to point out the bias of the studies. Both the funnel plot and Egger test showed no evidence of bias in the publication. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © Terms and Conditions

5 Fig E3 Galbraith radial plot. The figure shows the contribution of results from the patient groups treated with different doses of dupilumab in the different studies to the heterogeneity of efficacy of treatment. The following studies were included: phase IIb 300qw (1), phase IIb 200q2w (2), phase IIb 300q2w (3), phase IIb 100q4w (4), phase IIb 300q4w (5), M4 (6), M12 (7), C4 (8), SOLO1 300q2w (9), SOLO1 300qw (10), SOLO2 300q2w (11), and SOLO2 300qw (12). The group receiving 100 mg every 4 week (100q4w) in phase IIb study was found to be the main cause of the heterogeneity. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © Terms and Conditions

6 Fig E4 Forest plot of rate of AEs, SAEs, and study discontinuation in 7 RCTs. A, AE rates and RR of AE rates between dupilumab- and placebo-treated patients. B, SAE rates and RR of SAE rates between dupilumab- and placebo-treated patients. C, Rates of study discontinuation and RR of study discontinuation between dupilumab- and placebo-treated patients. Diamonds stand for the meta-analysis summary effect estimate. Blue dots represent the RR, and horizontal lines represent 95% CIs of the RR estimates. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © Terms and Conditions

Download ppt "Efficacy and safety of dupilumab for the treatment of adult atopic dermatitis: A meta- analysis of randomized clinical trials  Yue Han, MD, Yuxin Chen,"

Similar presentations

Faecalibacterium prausnitzii subspecies–level dysbiosis in the human gut microbiome underlying atopic dermatitis Han Song, PhD, Young Yoo, MD, PhD, Junghyun.

Faecalibacterium prausnitzii subspecies–level dysbiosis in the human gut microbiome underlying atopic dermatitis Han Song, PhD, Young Yoo, MD, PhD, Junghyun.
Yin-Shuo Chang, MD, Yu-Chen Huang, MD 

Yin-Shuo Chang, MD, Yu-Chen Huang, MD 
Does BCG vaccination protect against childhood asthma

Does BCG vaccination protect against childhood asthma
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Shuangbai San for Treating Primary Liver Cancer Patients With Cancer Pain  Xiaowei.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Shuangbai San for Treating Primary Liver Cancer Patients With Cancer Pain  Xiaowei.
Thomas F. O’Donnell, MD, Joseph Lau, MD  Journal of Vascular Surgery 

Thomas F. O’Donnell, MD, Joseph Lau, MD  Journal of Vascular Surgery 
Risk of an asthma exacerbation after bariatric surgery in adults

Risk of an asthma exacerbation after bariatric surgery in adults
Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo  Eli O. Meltzer, MD, Claus Bachert,

Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo  Eli O. Meltzer, MD, Claus Bachert,
Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 

Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 
Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials  Zuo-Tao Zhao, MD, PhD, Chun-Mei Ji, M Pharm,

Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials  Zuo-Tao Zhao, MD, PhD, Chun-Mei Ji, M Pharm,
In utero exposure to 25-hydroxyvitamin D and risk of childhood asthma, wheeze, and respiratory tract infections: A meta-analysis of birth cohort studies 

In utero exposure to 25-hydroxyvitamin D and risk of childhood asthma, wheeze, and respiratory tract infections: A meta-analysis of birth cohort studies 
The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria  Marcus Maurer, MD, Allen Kaplan, MD, Karin Rosén, MD, PhD, Michael Holden,

The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria  Marcus Maurer, MD, Allen Kaplan, MD, Karin Rosén, MD, PhD, Michael Holden,
Meta-analysis of randomized controlled trials on the efficacy and safety of ondansetron in preventing postanesthesia shivering  Min Li, Xiaolan Hu, Yuan.

Meta-analysis of randomized controlled trials on the efficacy and safety of ondansetron in preventing postanesthesia shivering  Min Li, Xiaolan Hu, Yuan.
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional.

Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional.
Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults  Peter S. Creticos, MD, Jennifer Maloney,

Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults  Peter S. Creticos, MD, Jennifer Maloney,
Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb

Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A meta-analysis–based comparison  Danilo Di.

Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A meta-analysis–based comparison  Danilo Di.
Maritta S. Jaakkola, MD, PhD, Reginald Quansah, PhD, Timo T

Maritta S. Jaakkola, MD, PhD, Reginald Quansah, PhD, Timo T
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis  Jennifer D. Hamilton, PhD, Mayte Suárez-Fariñas,

Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis  Jennifer D. Hamilton, PhD, Mayte Suárez-Fariñas,
OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild.

OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild.

Similar presentations

Ads by Google